DataSheet_1_Cost-Effectiveness Analysis of Imaging Modalities for Breast Cancer Surveillance Among BRCA1/2 Mutation Carriers: A Systematic Review.doc
BRCA1/2 mutation carriers are suggested with regular breast cancer surveillance screening strategies using mammography with supplementary MRI as an adjunct tool in Western countries. From a cost-effectiveness perspective, however, the benefits of screening modalities remain controversial among different mutated genes and screening schedules.
MethodsWe searched the MEDLINE/PubMed, Embase, Cochrane Library, Scopus, and Web of Science databases to collect and compare the results of different cost-effectiveness analyses. A simulated model was used to predict the impact of screening strategies in the target group on cost, life-year gained, quality-adjusted life years, and incremental cost-effectiveness ratio (ICER).
ResultsNine cost-effectiveness studies were included. Combined mammography and MRI strategy is cost-effective in BRCA1 mutation carriers for the middle-aged group (age 35 to 54). BRCA2 mutation carriers are less likely to benefit from adjunct MRI screening, which implies that mammography alone would be sufficient from a cost-effectiveness perspective, regardless of dense breast cancer.
ConclusionsPrecision screening strategies among BRCA1/2 mutation carriers should be conducted according to the acceptable ICER, i.e., a combination of mammography and MRI for BRCA1 mutation carriers and mammography alone for BRCA2 mutation carriers.
Systematic Review RegistrationPROSPERO, identifier CRD42020205471.
History
References
- https://doi.org//10.1001/jamaoncol.2019.0620
- https://doi.org//10.1056/NEJMoa1913948
- https://doi.org//10.1016/j.bjps.2009.06.034
- https://doi.org//10.1097/RMR.0b013e31818bc994
- https://doi.org//10.1016/S0140-6736%2812%2961611-0
- https://doi.org//10.1002/ijc.32211
- https://doi.org//10.3390/cancers10120477
- https://doi.org//10.1056/NEJMoa1903986
- https://doi.org//10.1007/s10549-020-05759-3
- https://doi.org//10.1002/jmrs.116
- https://doi.org//10.1007/s12609-013-0111-2
- https://doi.org//10.1093/jnci/djv367
- https://doi.org//10.1148/radiol.2017161218
- https://doi.org//10.1016/j.suc.2015.05.008
- https://doi.org//10.6004/jnccn.2020.0017
- https://doi.org//10.1093/annonc/mdw327
- https://doi.org//10.1016/j.breast.2015.03.013
- https://doi.org//10.1038/gim.2017.255
- https://doi.org//10.1007/s12630-008-9007-4
- https://doi.org//10.1136/bmj.b2535
- https://doi.org//10.1016/j.jval.2013.02.002
- https://doi.org//10.1001/jama.295.20.2374
- https://doi.org//10.1007/s10198-007-0042-9
- https://doi.org//10.1148/radiol.09091086
- https://doi.org//10.1002/cncr.27864
- https://doi.org//10.1016/j.ejca.2016.05.012
- https://doi.org//10.1016/j.breast.2019.03.004
- https://doi.org//10.1016/j.jacr.2008.10.003
- https://doi.org//10.1186/1471-2407-13-339
- https://doi.org//10.1007/s10549-010-1043-4
- https://doi.org//10.1001/jama.2020.9246
- https://doi.org//10.1111/j.1075-122X.2004.21375.x
- https://doi.org//10.1200/JCO.19.01525
- https://doi.org//10.1080/14737167.2018.1443810
- https://doi.org//10.2471/BLT.15.164418
- https://doi.org//10.1007/s10549-016-3912-y
- https://doi.org//10.1186/s13058-018-1019-6
- https://doi.org//10.1007/s10549-014-2888-8
- https://doi.org//10.1093/jnci/djn440
- https://doi.org//10.1038/bjc.2016.32
- https://doi.org//10.1016/S1470-2045%2819%2930275-X
- https://doi.org//10.1093/jnci/djz079
- https://doi.org//10.1158/1940-6207.CAPR-19-0506
- https://doi.org//10.2471/BLT.18.207944
- https://doi.org//10.1111/j.1349-7006.2009.01147.x
- https://doi.org//10.1016/S2214-109X%2818%2930127-X
- https://doi.org//10.1007/s10549-017-4247-z
- https://doi.org//10.1038/bjc.2014.458
- https://doi.org//10.1093/jnci/djt203
- https://doi.org//10.1001/jamaoncol.2020.2922
- https://doi.org//10.1186/s12885-018-4098-y
- https://doi.org//10.3390/cancers10120524
- https://doi.org//10.2147/CMAR.S211151
- https://doi.org//10.1007/s10198-017-0887-5
- https://doi.org//10.1097/GRF.0000000000000317
- https://doi.org//10.6004/jnccn.2020.7587
- https://doi.org//10.1186/s12885-017-3974-1
CC BY 4.0